Search

Author/Creator Ehrenstein, V

1. 1022PPopulation-based use of intravenous bisphosphonates in patients newly diagnosed with symptomatic multiple myeloma in Denmark in 2005-2015: Impact of patient characteristics. (23rd October 2018)

Authors:
Ehrenstein, V; Ording, A G; Ulrichsen, S P; Andersen, I T; Seesaghur, A; Helleberg, C; Silkjær, T; Hernandez, R; Niepel, D; Abildgaard, N
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort study. Issue 1 (4th January 2023)

Authors:
Willame, C; Dodd, C; Durán, CE; Elbers, RJHJ; Gini, R; Bartolini, C; Paoletti, O; Wang, L; Ehrenstein, V; Kahlert, J; Haug, U; Schink, T; Diez-Domingo, J; Mira-Iglesias, A; Carreras, JJ; Vergara-Hernández, C; Giaquinto, C; Barbieri, E; Stona, L; Huerta, C
Journal:
Vaccine
Issue:
Volume 41:Issue 1(2023)
Page Start:
251
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗